Deregulated mTOR-mediated translation in intellectual disability

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Local translation of dendritic mRNAs is crucial for brain development and function.
• Disruptions in dendrite and spine morphogenesis and synaptic plasticity are hallmarks of intellectual disability disorders.
• The mammalian target of rapamycin (mTOR) pathway regulates local translation and is implicated in neuronal development.

Purpose of the Study:

• To investigate the role of mTOR in intellectual disability.
• To explore the potential of mTOR inhibitors as a therapeutic strategy for cognitive impairments.

Main Methods:

• Analysis of mTOR pathway activity in mouse models of intellectual disability (Fragile X, tuberous sclerosis, Rett's syndrome, Down's syndrome).
• Assessment of local dendritic translation rates in these models.
• Administration of rapamycin (an mTOR inhibitor) to evaluate its effects on translation, synaptic plasticity, and behavior.

Main Results:

• Hyperactivation of mTOR and increased local dendritic translation were observed in multiple mouse models of intellectual disability.
• Rapamycin treatment normalized translation rates in Down's syndrome models.
• Rapamycin administration rescued behavioral and synaptic plasticity deficits in tuberous sclerosis models.

Conclusions:

• Deregulation of mTOR-dependent local translation is a common feature across various intellectual deficiencies.
• mTOR inhibitors, such as rapamycin, represent a potential therapeutic avenue for treating diverse forms of cognitive impairment.